Haleon plc (LON:HLN) Given Consensus Rating of “Moderate Buy” by Brokerages

Haleon plc (LON:HLN) has been given a consensus rating of “Moderate Buy” by the six brokerages that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have given a buy recommendation to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is GBX 395.33.

A number of brokerages recently weighed in on HLN. JPMorgan Chase & Co. reduced their price objective on Haleon from GBX 335 to GBX 315 and set an “underweight” rating on the stock in a research report on Thursday. Berenberg Bank restated a “buy” rating and set a GBX 512 price objective on shares of Haleon in a research report on Thursday, April 30th. Jefferies Financial Group reduced their price objective on Haleon from GBX 450 to GBX 400 and set a “buy” rating on the stock in a research report on Tuesday, May 5th. Finally, Royal Bank Of Canada restated a “sector perform” rating and set a GBX 370 price objective on shares of Haleon in a research report on Thursday, April 30th.

Haleon Trading Up 0.0%

Shares of HLN stock opened at GBX 348.30 on Friday. The firm has a market capitalization of £30.82 billion, a P/E ratio of 18.83, a P/E/G ratio of 1.49 and a beta of 0.25. Haleon has a twelve month low of GBX 317.80 and a twelve month high of GBX 416.10. The company has a quick ratio of 0.93, a current ratio of 0.92 and a debt-to-equity ratio of 52.26. The stock’s fifty day simple moving average is GBX 338.54 and its 200 day simple moving average is GBX 363.92.

About Haleon

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s product portfolio spans six major categories – Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands – such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren – are built on trusted science, innovation and deep human understanding.